Related Experiment Video
Updated: May 30, 2026
09:36
Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation
E N Gurzov1, J Barthson, I Marhfour
1Laboratory of Experimental Medicine, Université Libre de Bruxelles, Brussels, Belgium. egurzov@ulb.ac.be
Oncogene
|August 16, 2011
Summary
Type 1 diabetes involves autoimmune destruction of pancreatic beta cells. This study reveals JunB and ATF3 transcription factors protect beta cells from inflammatory damage, offering a potential therapeutic target.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Type 1 diabetes is characterized by autoimmune destruction of insulin-producing pancreatic beta cells.
- Autoimmune inflammation triggers cellular stress responses within pancreatic islets.
Purpose of the Study:
- To investigate the role of transcription factor JunB/AP-1 in beta cell survival during autoimmune inflammation.
- To identify downstream targets of JunB involved in protecting beta cells from cytokine-induced apoptosis.
Main Methods:
- Histochemical analysis of pancreatic tissues from non-obese diabetic mice.
- In vitro studies using human and rodent beta cells treated with tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ).
- Microarray analysis to identify JunB-regulated genes; confirmation using Ubi-JunB transgenic mice and pharmacological cAMP modulation.
Main Results:
- JunB expression is activated following autoimmune infiltration of islets.
- TNF-α and IFN-γ induce JunB expression, which protects beta cells from apoptosis.
- JunB regulates approximately 20% of cytokine-modified beta cell genes, including the transcription factor ATF3.
- Direct induction of ATF3 by JunB is crucial for beta cell survival.
- Upregulation of JunB/ATF3 via cAMP enhances beta cell resistance to inflammatory mediators.
Conclusions:
- JunB acts as a key survival factor for pancreatic beta cells under inflammatory stress.
- ATF3 is identified as a novel downstream target of JunB in this protective pathway.
- Targeting the JunB/ATF3 pathway presents a potential therapeutic strategy for type 1 diabetes.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
Related Concept Videos
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...